Table 2.
Study mean | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | Mean annual changea (95% CI) | |
---|---|---|---|---|---|---|---|---|---|---|
All RTIs | ||||||||||
Episode rateb | 284 | 312 | 285 | 266 | 284 | 284 | 281 | 280 | 277 | −2.6 (−7.1 to 1.9) |
Antibiotic prescription ratec | 29 | 37 | 34 | 33 | 30 | 28 | 25 | 23 | 23 | −2.1 (−2.4 to −1.7)d |
PcV proportion (%)e | 47 | 40 | 44 | 45 | 46 | 48 | 51 | 52 | 53 | 1.8 (1.5 to 2.1)d |
Diagnosis-specific ICPC-2 codes | ||||||||||
Episode rate | 193 | 218 | 197 | 179 | 193 | 193 | 191 | 192 | 187 | −2.6 (−6.4 to 1.3) |
Antibiotic prescription rate | 37 | 45 | 42 | 42 | 38 | 36 | 33 | 30 | 31 | −2.3 (−2.8 to −1.9)d |
PcV proportion (%) | 48 | 42 | 46 | 46 | 47 | 50 | 53 | 54 | 55 | 1.8 (1.5 to 2.2)d |
Symptom-related ICPC-2 codes | ||||||||||
Episode rate | 90 | 93 | 87 | 87 | 91 | 91 | 90 | 88 | 91 | −0.1 (−0.9 to 0.8) |
Antibiotic prescription rate | 12 | 17 | 14 | 13 | 12 | 11 | 9 | 9 | 8 | −1.2 (−1.4 to −1.0)d |
PcV proportion (%) | 35 | 30 | 33 | 35 | 35 | 36 | 37 | 38 | 39 | 1.2 (0.9 to 1.4)d |
URTI (R74) | ||||||||||
Episode rate | 65 | 63 | 59 | 58 | 63 | 65 | 70 | 71 | 75 | 2.2 (1.1 to 3.3)d |
Antibiotic prescription rate | 18 | 24 | 22 | 21 | 19 | 17 | 15 | 14 | 14 | −1.6 (−1.9 to −1.3)d |
PcV proportion (%) | 56 | 50 | 54 | 54 | 55 | 57 | 60 | 62 | 62 | 1.7 (1.3 to 2.1)d |
Sinusitis (R75) | ||||||||||
Episode rate | 26 | 32 | 30 | 27 | 27 | 25 | 24 | 22 | 22 | −1.5 (−1.7 to −1.2)d |
Antibiotic prescription rate | 57 | 65 | 64 | 61 | 59 | 55 | 51 | 49 | 49 | −2.7 (−3.1 to −2.3)d |
PcV proportion (%) | 50 | 46 | 47 | 48 | 49 | 51 | 55 | 56 | 57 | 1.7 (1.3 to 2.2)d |
Sinus symptoms (R09) | ||||||||||
Episode rate | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 5 | 6 | 0.2 (0.1 to 0.3)d |
Antibiotic prescription rate | 24 | 32 | 31 | 28 | 27 | 24 | 20 | 19 | 19 | −2.1 (−2.5 to −1.8)d |
PcV proportion (%) | 44 | 41 | 42 | 42 | 43 | 43 | 46 | 47 | 48 | 1.0 (0.7 to 1.4)d |
Tonsillitis (R72 + R76) | ||||||||||
Episode rate | 12 | 15 | 13 | 13 | 12 | 12 | 12 | 11 | 11 | −0.5 (−0.7 to −0.3)d |
Antibiotic prescription rate | 76 | 76 | 76 | 76 | 77 | 76 | 75 | 74 | 76 | −0.2 (−0.4 to 0.0) |
PcV proportion (%) | 83 | 80 | 81 | 81 | 82 | 84 | 86 | 86 | 87 | 1.1 (0.9 to 1.3)d |
Throat symptoms (R21) | ||||||||||
Episode rate | 15 | 16 | 15 | 15 | 15 | 15 | 15 | 14 | 15 | −0.1 (−0.2 to 0.1) |
Antibiotic prescription rate | 15 | 20 | 19 | 18 | 17 | 15 | 13 | 12 | 11 | −1.3 (−1.5 to −1.2)d |
PcV proportion (%) | 66 | 64 | 64 | 66 | 66 | 67 | 69 | 69 | 70 | 0.8 (0.7 to 1.0)d |
Acute bronchitis (R78) | ||||||||||
Episode rate | 27 | 31 | 26 | 26 | 30 | 30 | 28 | 24 | 22 | −0.8 (−1.8 to 0.2) |
Antibiotic prescription rate | 44 | 57 | 53 | 50 | 45 | 41 | 36 | 34 | 36 | −3.4 (−4.1 to −2.6)d |
PcV proportion (%) | 25 | 20 | 23 | 24 | 25 | 27 | 30 | 30 | 29 | 1.5 (1.0 to 2.0)d |
Pneumonia (R81) | ||||||||||
Episode rate | 21 | 29 | 23 | 21 | 22 | 21 | 21 | 19 | 17 | −1.2 (−1.9 to −0.5)d |
Antibiotic prescription rate | 66 | 68 | 66 | 67 | 67 | 67 | 66 | 64 | 65 | −0.4 (−0.6 to −0.1)d |
PcV proportion (%) | 40 | 34 | 38 | 38 | 40 | 42 | 44 | 45 | 45 | 1.6 (1.1 to 2.0)d |
Cough (R05) | ||||||||||
Episode rate | 37 | 41 | 37 | 35 | 37 | 37 | 37 | 35 | 34 | −0.6 (−1.2 to 0.0) |
Antibiotic prescription rate | 13 | 20 | 16 | 15 | 14 | 12 | 10 | 9 | 9 | −1.5 (−1.8 to −1.2)d |
PcV proportion (%) | 20 | 16 | 19 | 19 | 20 | 21 | 23 | 24 | 24 | 1.1 (0.9 to 1.3)d |
Influenza (R80) | ||||||||||
Episode rate | 19 | 19 | 22 | 13 | 20 | 20 | 18 | 26 | 16 | 0.2 (−1.3 to 1.7) |
Antibiotic prescription rate | 7 | 9 | 8 | 8 | 7 | 7 | 6 | 5 | 5 | −0.6 (−0.7 to −0.5)d |
PcV proportion (%) | 41 | 35 | 39 | 39 | 39 | 43 | 43 | 45 | 44 | 1.2 (0.7 to 1.7)d |
Mean annual change represents coefficient from linear regression with 95% CI.
Episode rate: episodes per 1000 inhabitants adjusted for age and sex.
Antibiotic prescription rate: proportion of episodes receiving ≥1 prescription within 7 days.
P value <0.05.
PcV proportion (%): phenoxymethylpenicillin as proportion of all first prescriptions.